Summary

In work that Science ranked as a runner-up for Breakthrough of the Year, researchers used structural biology—the study of the molecules of life—to design the key ingredient of a vaccine against a dangerous childhood disease. Respiratory syncytial virus (RSV) infections hospitalize millions of infants every year. This year, scientists crystallized an antibody the body uses to combat RSV; then they analyzed its structure and used the information to design an immunogen that may lead to a vaccine. Other researchers hope a similar approach will yield new HIV drugs.

In Vaccine Design, Looks Do Matter

Science20 Dec 2013 : 1442-1443

In work that Science ranked as a runner-up for Breakthrough of the Year, researchers used structural biology—the study of the molecules of life—to design the key ingredient of a vaccine against a dangerous childhood disease.

Citation Manager Formats

In Vaccine Design, Looks Do Matter

Science20 Dec 2013 : 1442-1443

In work that Science ranked as a runner-up for Breakthrough of the Year, researchers used structural biology—the study of the molecules of life—to design the key ingredient of a vaccine against a dangerous childhood disease.